Nvidia Continues To Defy The Odds

Nvidia Q2 revenue more than doubled YoY to $96B, supporting continued strength in AI demand. However, management still frames FY2028 growth as supply-constrained (not demand-constrained), tempering the durability narrative. The rise of ACIE and broader enterprise AI adoption (including new revenue models) reduces reliance on a few hyperscalers, but residual cyclicality risk remains.

Analysis

The key mechanism is not just more AI spend, but a revenue stream that is becoming harder to choke off through customer concentration. If demand is broadening beyond the hyperscaler cohort into enterprise and custom accelerator deployments, the market should assign a slightly lower cyclicality discount to NVDA’s earnings power and a higher terminal multiple to the data-center franchise.

The second-order winner set is broader than NVDA: TSMC, HBM suppliers, advanced packaging, and substrate capacity all stay tight if supply is the binding constraint. The flip side is that persistent scarcity encourages more in-house silicon and architectural substitution at the largest buyers, which can quietly pressure merchant GPU share over 6-18 months even if top-line growth stays strong.

Near term, the stock is more likely to trade on whether gross margin and backlog commentary confirm that supply remains the bottleneck, rather than on headline revenue growth. The contrarian risk is that investors extrapolate scarcity as demand robustness; if lead times normalize or a hyperscaler signals capex digestion, the multiple can compress even before growth decelerates. A cleaner falsifier is any guidance that implies easing supply into the next 2-3 quarters or a step-down in pricing power.

The base case is constructive but not a chase-after-print setup: the upside is slower estimate revisions and a gradual de-risking of concentration, not an immediate re-rating to an extreme multiple. If management continues to frame growth as constrained by capacity rather than demand, that supports the bull thesis; if not, the market will likely punish the stock first on duration and valuation, not on absolute growth.

Key Decisions for Investors

• Maintain a tactical long NVDA bias into the next print, but add only on 3-5% pullbacks; the trade is estimate revisions, not headline revenue surprise.
• Use a call spread in NVDA for the next 1-2 earnings cycles if implied vol is reasonable; upside is tied to supply commentary, while downside is capped if demand remains intact.
• Consider a pair: long NVDA / short SMH on any post-earnings strength if semis broadly lag; NVDA should outperform peers if the market rewards scarce supply and backlog visibility.
• Watch TSM, AVGO, and HBM-related supply indicators as confirmation signals; if packaging or memory capacity loosens, reduce NVDA exposure because the scarcity premium can fade quickly.
• If management hints at easing supply or slower enterprise adoption, treat that as a falsifier and trim longs immediately; that would shift the stock from scarcity beneficiary to normalizing growth multiple.